Ana Barrera-Vargas

Ana Barrera-Vargas

Auto-generated profile, based on publicly available information

Ana Barrera-Vargas

Department of Medical Education, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LOLiam O'Neil
Liam O'Neil
ABAna Barrera-Vargas
Ana Barrera-Vargas
DSDonavon Sandoval-Heglund
Donavon Sandoval-Heglund
JMJavier Merayo-Chalico
Javier Merayo-Chalico
EAEduardo Aguirre-Aguilar
Eduardo Aguirre-Aguilar
CCCarmelo Carmona-Rivera
Carmelo Carmona-Rivera
Carbamylated histone antibodies potentiate osteoclast formation and associate with bone erosion in rheumatoid arthritis.

22 February 2023 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
JHJosé Joel Hurtado-Arias
José Joel Hurtado-Arias
IRIsabela Ramírez-Mulhern
Isabela Ramírez-Mulhern
CGCarlos Gonzalez-Martínez
Carlos Gonzalez-Martínez
JMJavier Merayo-Chalico
Javier Merayo-Chalico
ABAna Barrera-Vargas
Ana Barrera-Vargas
AHAndrea Hinojosa-Azaola
Andrea Hinojosa-Azaola

15 June 2022 in Lupus
Verified
Journal Article
Closed access
JCJonathan Campos-Guzmán
Jonathan Campos-Guzmán
MVMartín Valdez-López
Martín Valdez-López
SGSamuel Govea-Peláez
Samuel Govea-Peláez
EAEduardo Aguirre-Aguilar
Eduardo Aguirre-Aguilar
LPLuis F Perez-Garcia
Luis F Perez-Garcia
JMJavier Merayo-Chalico
Javier Merayo-Chalico
Objectives: Our study aims to describe the association between SLE and sexual function, analysing demographic variables, comorbidities and other disease-related factors. As an exploratory objective, the impact of asking about sexual function during outpatient consultation was evaluated. Methods: From 2018 to 2019, we invited sexually active men diagnosed with SLE to complete questionnaires that evaluated their sexual function and quality of life. Additionally, patients were asked if they believed they had sexual dysfunction, whether they would be interested in receiving specialized sexual care, and if they considered SLE to be detrimental to their sexual function. Epidemiological and disease-related data were retrieved from the patients’ clinical records. Results: We included 124 men with SLE. Twenty-two (18%) patients answered positively when asked if they believed they had sexual dysfunction. These patients had lower overall erectile function scores and lower physical function scores than those who did not consider they had sexual dysfunction. In the multivariable analysis, factors that were associated with better sexual function were high physical function (B = 0.126, p = .031), lower BMI (B = 0.53, p = .010) and the patient’s perception of normal sexual function (B = 13.0, p < .001). Comorbidities associated with worse sexual function were type 2 diabetes (B = −8.1, p = .017) and a history of thrombosis (B = −5.12, p = .019). Conclusion: Sexual function of male patients with SLE is impaired, independently of disease activity, chronic disease damage or pharmacological treatment. A simple question about perception of sexual function in the outpatient clinic can be used to help determine which patients could benefit from a multidisciplinary intervention to improve sexual health.

30 August 2021 in Lupus
Verified
Journal Article
Closed access
PDF file
JGJessica González-Rangel
Jessica González-Rangel
BPBrenda Pérez-Muñoz
Brenda Pérez-Muñoz
DCDaniela Casillas-Santos
Daniela Casillas-Santos
ABAna Barrera-Vargas
Ana Barrera-Vargas
PVPaola Vázquez-Cardenas
Paola Vázquez-Cardenas
JMJavier Merayo-Chalico
Javier Merayo-Chalico
Objective: To determine the factors associated with anxiety, depression, and concern within the COVID-19 pandemic in a population with autoimmune diseases. Methods: A telephonic survey was conducted during the early stages of the pandemic in a tertiary care center, which included patients with systemic autoimmune diseases. Mental health variables were assessed with Patient Health Questionnaire 2, General Anxiety Disorder 7 scores, and pandemic-related concern questions. Sociodemographic aspects were also evaluated. Results: Of the total 334 participants, 291 (87.1%) were women, with a median age of 46 years; systemic lupus erythematosus (SLE) was the most frequent diagnosis (144, 43.2%); 44 patients (13.2%) showed depression and 32 (9.6%) anxiety. The variables associated with depression were all the pandemic concern items, body mass index, anxiety, and a higher COVID-19 symptom score. Anxiety was associated with depression, all pandemic concern items, and a higher COVID-19 symptom score. Women presented higher scores in all concern items. The SLE group presented higher scores in concern questions and difficulty finding medication. Conclusion: During the COVID-19 outbreak, rheumatic patients are vulnerable to psychiatric conditions, which makes it imperative for physicians who treat these patients to pay careful attention in order to detect them promptly and to settle coping strategies.


1 February 2022 in Archives of Medical Research
Verified
Journal Article
Closed access
LCLilian Guadalupe Cano-Cruz
Lilian Guadalupe Cano-Cruz
ABAna Barrera-Vargas
Ana Barrera-Vargas
AMAbigail Mateos-Soria
Abigail Mateos-Soria
ESEnrique Soto-Pérez-De-Celis
Enrique Soto-Pérez-De-Celis
JMJavier Merayo-Chalico
Javier Merayo-Chalico